Found: 156
Select item for more details and to access through your institution.
Acute myeloid leukemia with misleading cytology.
- Published in:
- International Journal of Laboratory Hematology, 2024, v. 46, n. 4, p. 583, doi. 10.1111/ijlh.14233
- By:
- Publication type:
- Article
Solitary central nervous system relapse in acute promyelocytic leukemia.
- Published in:
- International Journal of Laboratory Hematology, 2024, v. 46, n. 4, p. 587, doi. 10.1111/ijlh.14241
- By:
- Publication type:
- Article
Perianal Injury Prevention in Patients With Leukemia.
- Published in:
- Clinical Journal of Oncology Nursing, 2024, v. 28, n. 2, p. 149, doi. 10.1188/24.CJON.149-156
- By:
- Publication type:
- Article
Hypercalcemia associated with interaction between all trans retinoic acid and fluconazole in an acute promyelocytic leukemia and acquired hypoparathyroidism case.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 3, p. 605, doi. 10.1177/10781552231216050
- By:
- Publication type:
- Article
In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo–keto reductases.
- Published in:
- Archives of Toxicology, 2024, v. 98, n. 3, p. 807, doi. 10.1007/s00204-023-03661-7
- By:
- Publication type:
- Article
Detection of Genomic Structural Variations Associated with Drug Sensitivity and Resistance in Acute Leukemia.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 418, doi. 10.3390/cancers16020418
- By:
- Publication type:
- Article
A Phase I Trial of Sirolimus with "7&3" Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5129, doi. 10.3390/cancers15215129
- By:
- Publication type:
- Article
Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2695, doi. 10.1007/s00277-023-05400-5
- By:
- Publication type:
- Article
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3145, doi. 10.3390/cancers15123145
- By:
- Publication type:
- Article
A prospective cohort study of methotrexate plus idarubicin in newly diagnosed primary CNS lymphoma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 163, n. 1, p. 39, doi. 10.1007/s11060-022-04062-z
- By:
- Publication type:
- Article
The feasibility of PETHEMA ALL-96 regimen on treatment of patients with acute lymphoid leukemia.
- Published in:
- Journal of Research in Medical Sciences, 2023, v. 28, n. 4, p. 1, doi. 10.4103/jrms.jrms_4_22
- By:
- Publication type:
- Article
Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia.
- Published in:
- In Vivo, 2023, v. 37, n. 2, p. 924, doi. 10.21873/invivo.13164
- By:
- Publication type:
- Article
Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up—A Single Center Experience.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4716, doi. 10.3390/cancers14194716
- By:
- Publication type:
- Article
Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML‐2003 study by the Finnish Leukemia Group
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 257, doi. 10.1111/ejh.13805
- By:
- Publication type:
- Article
Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 6, p. 1474, doi. 10.1177/10781552221076756
- By:
- Publication type:
- Article
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 535, doi. 10.1111/bjh.18193
- By:
- Publication type:
- Article
Life-Saving Effect of Corticosteroid and Colchicine Combination in Acute Myeloid Leukemia: Case Report.
- Published in:
- Middle East Journal of Cancer, 2022, v. 13, n. 3, p. 556, doi. 10.30476/mejc.2022.87974.1449
- By:
- Publication type:
- Article
Apoferritin nanocages for targeted delivery of idarubicin against breast cancer cells.
- Published in:
- Biotechnology & Applied Biochemistry, 2022, v. 69, n. 3, p. 1061, doi. 10.1002/bab.2177
- By:
- Publication type:
- Article
Benefit of high-dose idarubicin as induction therapy in acute myeloid leukemia: a prospective phase 2 study.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 4, p. 831, doi. 10.1007/s00277-022-04764-4
- By:
- Publication type:
- Article
Electrochemical Sensing of Idarubicin—DNA Interaction Using Electropolymerized Azure B and Methylene Blue Mediation.
- Published in:
- Chemosensors, 2022, v. 10, n. 1, p. 33, doi. 10.3390/chemosensors10010033
- By:
- Publication type:
- Article
Alternate application of all-trans-retinoic acid and arsenic trioxide combined with idarubicin/daunorubicin in treatment of acute promyelocytic leukemia.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2022, v. 35, n. 1, p. 23, doi. 10.36721/PJPS.2022.35.1.REG.023-028.1
- By:
- Publication type:
- Article
Fortuitous discovery of an NPM1 mutation in a myelodysplastic syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with Isolated Thrombocytosis.
- Published in:
- Turkish Journal of Hematology, 2021, v. 38, n. 4, p. 341, doi. 10.4274/tjh.galenos.2021.2021.0546
- By:
- Publication type:
- Article
Miliaria crystallina induced by idarubicin and all‐trans‐retinoic acid: Two case reports.
- Published in:
- Australasian Journal of Dermatology, 2021, v. 62, n. 3, p. e408, doi. 10.1111/ajd.13641
- By:
- Publication type:
- Article
Clinical Characteristics and Optimal Therapy of Acute Myeloid Leukemia with Myelodysplasia-Related Changes: A Retrospective Analysis of a Cohort of Chinese Patients.
- Published in:
- Turkish Journal of Hematology, 2021, v. 38, n. 3, p. 188, doi. 10.4274/tjh.galenos.2021.2021.0009
- By:
- Publication type:
- Article
NPM1+ /FLT3- Acute Myeloid Leukemia after JAK2-V617F+ Essential Thrombocythemia. Management and Prognosis.
- Published in:
- Plasmatology, 2021, v. 15, p. 1, doi. 10.1177/26348535211028192
- By:
- Publication type:
- Article
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Optimized Loading of Idarubicin in CalliSpheres ® Drug-Eluting Beads and Characterization of Release Profiles and Morphological Properties.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 6, p. 799, doi. 10.3390/pharmaceutics13060799
- By:
- Publication type:
- Article
Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin's lymphoma patients.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-81944-8
- By:
- Publication type:
- Article
Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3 -ITD in NPM1 Mutated AML, Irrespectively of FLT3 -ITD Allelic Burden.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 34, doi. 10.3390/cancers13010034
- By:
- Publication type:
- Article
Comparison of Thermodynamic Functions of Idarubicin Cancer Drug Interaction with Carbon Nanotube: QM/MM studies.
- Published in:
- International Journal of New Chemistry, 2021, v. 8, n. 1, p. 30, doi. 10.22034/ijnc.2020.120639.1089
- By:
- Publication type:
- Article
Sensitive Analysis of Idarubicin in Human Urine and Plasma by Liquid Chromatography with Fluorescence Detection: An Application in Drug Monitoring.
- Published in:
- Molecules, 2020, v. 25, n. 24, p. 5799, doi. 10.3390/molecules25245799
- By:
- Publication type:
- Article
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 754, doi. 10.1002/hon.2806
- By:
- Publication type:
- Article
Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 8, p. 2034, doi. 10.1177/1078155220915764
- By:
- Publication type:
- Article
Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3405, doi. 10.3390/cancers12113405
- By:
- Publication type:
- Article
Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2933, doi. 10.3390/cancers12102933
- By:
- Publication type:
- Article
Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 531, doi. 10.1002/hon.2755
- By:
- Publication type:
- Article
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 3, p. e169, doi. 10.1111/bjh.16804
- By:
- Publication type:
- Article
PI3K Abrogation Using Pan-PI3K Inhibitor BKM120 Gives Rise to a Significant Anticancer Effect on AML-Derived KG-1 Cells by Inducing Apoptosis and G2/M Arrest.
- Published in:
- Turkish Journal of Hematology, 2020, v. 37, n. 3, p. 167, doi. 10.4274/tjh.galenos.2020.2019.0440
- By:
- Publication type:
- Article
Carbon-based ruthenium nanomaterial-based electroanalytical sensors for the detection of anticancer drug Idarubicin.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-68055-6
- By:
- Publication type:
- Article
Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Electrochemical Determination of the Effect of Caffeic Acid onto the Interaction between Idarubicin and DNA by Single‐use Disposable Electrodes.
- Published in:
- Electroanalysis, 2020, v. 32, n. 6, p. 1288, doi. 10.1002/elan.201900722
- By:
- Publication type:
- Article
Long‐term follow‐up of Cladribine, high‐dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 6, p. 538, doi. 10.1111/ejh.13395
- By:
- Publication type:
- Article
Designing Biodegradable Wafers Based on Poly(L-lactide-co-glycolide) and Poly(glycolide-co-ε-caprolactone) for the Prolonged and Local Release of Idarubicin for the Therapy of Glioblastoma Multiforme.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 5, p. 1, doi. 10.1007/s11095-020-02810-2
- By:
- Publication type:
- Article
Intra-arterial idarubicin_lipiodol without embolization can provide prolonged complete response in hepatocellular carcinoma: A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 2, p. 507, doi. 10.1177/1078155219861422
- By:
- Publication type:
- Article
Tetrazolium-Based Cytotoxicity Tests May Not Always Reflect Accurate Results.
- Published in:
- Journal of Harran University Medical Faculty / Harran Üniversitesi Tıp Fakültesi Dergisi, 2020, v. 17, n. 1, p. 6, doi. 10.35440/hutfd.600652
- By:
- Publication type:
- Article
FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1831, doi. 10.1177/1078155218817816
- By:
- Publication type:
- Article
Ovarian cyst haemorrhage as a complication of acute myelomonocytic leukaemia induction therapy.
- Published in:
- Clinical Medicine, 2019, v. 19, n. 6, p. 509
- By:
- Publication type:
- Article
Chronic myelomonocytic leukaemia: leukaemia cutis predicts disease progression.
- Published in:
- 2019
- By:
- Publication type:
- Case Study